These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7605242)

  • 21. [Chronic left heart ventricle failure and inotropic stimulation].
    Myhre ES; Gundersen T; Dickstein K; Hole T; Kjekshus J; Rønnevik P; Smith P; Westheim A
    Tidsskr Nor Laegeforen; 1995 Jan; 115(3):360-4. PubMed ID: 7855836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Classification and principles of the use of vasodilators in the treatment of left ventricular insufficiency].
    Weber S; Pailleret JJ; Cattan S; Guérin F; Degeorges M
    Ann Med Interne (Paris); 1985; 136(3):256-60. PubMed ID: 3927808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Management of pulmonary circulation alterations].
    Quero Jiménez MC; Burgueros Valero M; González Dieguez C; Domínguez Pérez F; Pinto Corraliza J; Rodríguez Fernández M
    Rev Esp Cardiol; 1993; 46 Suppl 2():13-28. PubMed ID: 7905203
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of vasodilator and inotropic drugs on clinical symptoms and long-term survival in chronic congestive heart failure.
    Packer M
    Eur Heart J; 1988 Jun; 9 Suppl H():105-8. PubMed ID: 2901957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the treatment of congestive heart failure: inotropic agents and calcium channel blockers.
    Hilleman DE
    Pharmacotherapy; 1993; 13(5 Pt 2):88S-93S. PubMed ID: 7901842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Arterial hypertension and cardiac decompensation].
    Degaute JP
    Rev Med Brux; 1996 Sep; 17(4):272-4. PubMed ID: 8927860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of cilazapril on exercise tolerance and neurohumoral factors in patients with asymptomatic chronic heart failure after myocardial infarction].
    Fujiwara M; Asakuma S; Nakamura T; Nakamura K; Iwasaki T
    J Cardiol; 1995 Nov; 26(5):287-92. PubMed ID: 8523261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Two sides of the coin, or converting enzyme inhibitors in the therapy of heart failure].
    Guazzi MD; Berti M; Dardani M; Muratori E; Guazzi M
    Cardiologia; 1989 Jan; 34(1):15-8. PubMed ID: 2655899
    [No Abstract]   [Full Text] [Related]  

  • 29. The evolving role of angiotensin-converting enzyme inhibition in heart failure: expanding the protective envelope.
    Teerlink JR
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S32-7. PubMed ID: 7700062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinico-pharmacologic aspects of cardioactive drugs].
    Erdmann E; Schwinger RH; Böhm M
    Klin Anasthesiol Intensivther; 1995; 47():46-60. PubMed ID: 7715179
    [No Abstract]   [Full Text] [Related]  

  • 31. [Vasodilators in chronic heart insufficiency].
    Bucher HJ
    Schweiz Rundsch Med Prax; 1986 Jan; 75(4):61-3. PubMed ID: 3952406
    [No Abstract]   [Full Text] [Related]  

  • 32. Vasodilator therapy of heart failure. Has the promissory note been paid?
    Braunwald E; Colucci WS
    N Engl J Med; 1984 Feb; 310(7):459-61. PubMed ID: 6363928
    [No Abstract]   [Full Text] [Related]  

  • 33. New medical therapies for advanced left ventricular dysfunction.
    Baughman K
    Cardiol Clin; 1995 Feb; 13(1):27-34. PubMed ID: 7796429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Converting enzyme inhibitors and calcium antagonists in left ventricular dysfunction].
    Hertzeanu H; Fenig A
    Harefuah; 1986 Jun; 110(12):624-8. PubMed ID: 3023212
    [No Abstract]   [Full Text] [Related]  

  • 36. [Oral vasodilators in the treatment of congestive heart failure].
    Pérez-Olea J
    Rev Med Chil; 1996 Oct; 124(10):1256-60. PubMed ID: 9239917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vasodilator agents in chronic heart failure: which is the best option?].
    Corbalán R; Kunstmann S; Jalil J
    Rev Med Chil; 1993 Jan; 121(1):81-8. PubMed ID: 8235172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin inhibitors and other vasodilators with special reference to congestive heart failure.
    Chatterjee K; Opie LH
    Cardiovasc Drugs Ther; 1987; 1(1):1-8. PubMed ID: 3154305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managing a failing heart.
    Solomon J
    RN; 1991 Aug; 54(8):46-51. PubMed ID: 1807256
    [No Abstract]   [Full Text] [Related]  

  • 40. [Vasodilators in the therapy of congestive heart failure].
    Manzoli U; Schiavoni G
    Cardiologia; 1986 Oct; 31(10):827-31. PubMed ID: 3815426
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.